Patent application title: Pure-Sip
Inventors:
John James Mcencroe (Golden, CO, US)
IPC8 Class: AC02F900FI
USPC Class:
210251
Class name: Liquid purification or separation combined
Publication date: 2014-04-17
Patent application number: 20140102968
Abstract:
Endocrine disrupting compounds are routinely detected in the treated
water leaving our municipal drinking water plants; however, until
relatively recent advances in laboratory analysis capabilities, the trace
amounts of these chemicals was not measurable. At an enormous cost we can
remove these compounds using centralized municipal water treatment, but
does it make sense to do so when less than 1% of our municipal water
supply is ingested? Furthermore, 1/3 of waterborne disease outbreaks can
be traced to contamination entering our water distribution systems after
centralized treatment. The regulatory community and municipal water
industry are truly at a crossroads, even if a staggering investment is
made to remove endocrine disrupting compounds using centralized
treatment, our treated water distribution systems will always be subject
to contamination. The countertop (portable) "Pure Sip"® low voltage
Point-of-Use water treatment system uses filtration, adsorption, and UV
disinfection to reliably and economically address these exposures.Claims:
1. The first 12 volt DC (other "safe" low voltages are included)
countertop "Point of Use" water treatment system which will fit in the
typical 18'' space found between overhead and base cabinets in a kitchen
which incorporates the following processes in a single unit in this
order: i. A flow inhibitor device to ensure adequate contact time with
the UV source for disinfection, and with the carbon block filter(s) to
ensure adequate adsorption time for organics removal ii. A≦50
micron particle/sediment filter (upstream of UV disinfection to minimize
dispersion/blockage of UV energy and upstream of≦3.0 micron
filtration to avoid premature clogging) iii. Class "A" Ultraviolet
disinfection which meets NSF 55 to inactivate opportunistic or frank
pathogens iv. ≦3.0 micron filtration for inorganics and microbial
removal coupled with carbon adsorption for organics removal (the chassis
is designed to accommodate up to four filtration/adsorption cartridges
for highly impacted waters, including those with polar compounds) v.
Class "A" Ultraviolet disinfection which meets NSF 55 to inactivate
opportunistic or frank pathogens which survive the 1.sup.st stage UV
disinfection
2. The system is portable so that it can be used anywhere a 12 Volt DC (or other "safe" low voltage is available), the low voltage powers the Ultraviolet disinfection processes as well as the system pump.
3. A syringe is included which will allow manually forcing water through the components in the event of pump failure, unavailability of a low voltage power source, or civil emergency. Those units equipped with ≦˜0.45 micron filtration will physically exclude pathogenic bacteria. The syringe connection at the influent tank is generic so that those wishing to connect the system to a faucet or under counter could have the same connectors on their house plumbing (the same applies to the effluent tank connection upstream of a dedicated faucet).
4. A chlorine disinfectant residual test kit is included as part of the system; absence of chlorine in the unit's effluent serves as a surrogate to verify the efficacy of the carbon block filter(s) at adsorbing organic contaminants.
Description:
[0001] The system for which I seek a process patent uses existing
technologies in a configuration which is unique and which provides
requisite flexibility for everyday use in the home, portable use away
from home, and water purification during civil emergencies. Unlike
bottled water which is processed in a controlled environment and then
distributed in tamper evident packaging (and which may be unavailable
during civil emergencies when most needed), municipally treated water is
pumped through a complicated water distribution system in which there are
numerous potential places for contamination and which are not under the
direct control of the water supplier. Indeed, one study found that 30.3%
of waterborne disease outbreaks in the United States could be traced to
our treated water distribution systems (Craun & Calderon 2001). The
"Pure-Sip" Point-of-Use process can essentially eliminate outbreaks
related to distribution system contamination events. In addition to
concerns with contamination of treated water within our distribution
systems, there are trace amounts of human made chemicals, such as
endocrine disrupting compounds, which are routinely detected in the
treated water leaving our municipal drinking water plants. Until
relatively recent advances in laboratory analysis capabilities the
presence of trace amounts of these chemicals was not measurable. Dr.
Joerg Drewes (formerly at Colorado School of Mines and now at the
University of Munich) stated his concern about these chemicals as
follows: "In addition to concerns about individual endocrine disrupting
compounds, there is concern about the cocktail effect of numerous
micropollutants and/or their metabolites" (lecture notes from ESGN 603 at
Colorado School of Mines, Sep. 9, 2004). Indeed, there are over 83,000
chemicals currently in the TSCA inventory (testimony before the
Subcommittee on Commerce, Trade, and Consumer Protection, Committee on
Energy and Commerce, House of Representatives by John Stephenson,
Director Natural Resources and the Environment--GAO, Fe. 26, 2009,
GAO-09-428T "Chemical Regulation, Options for Enhancing the Effectiveness
of TSCA"). The regulatory community and municipal water industry are at a
crossroads. At an enormous cost we can remove these trace contaminants
using centralized municipal water treatment, but does it make sense to do
so when less than 1% of our municipal water supply is ingested (Vickers
2001), and when we know that 1/3 of disease outbreaks attributable to our
potable water systems can be traced to our water distribution systems?
[0002] There are numerous manufacturers of "Point-of-Use" water treatment systems. My unique "Pure Sip" Point-of-Use treatment system is a logical, economical, and effective, addition to the water industry's traditional "multiple barrier" treatment strategy. Although under counter systems are preferred from an aesthetic standpoint, they are "out of sight--out of mind" and their installation and maintenance will be perceived as problematic, or essentially impossible, by most utilities (please note however that my process allows for such installation by the use of commonly available quick disconnect couplings in the influent and effluent tanks for connection to the water supply line [or sink faucet] and to a dedicated faucet). To be successful in persuading the EPA, state and local Health Departments, and Utilities to embrace Point-of-Use, they need a free standing countertop design which eliminates the nebulous variables and costs related to under counter installations, is convenient for the citizen and the utility to swap out on a scheduled basis (generally every six months, but variable depending on water system quality), and which protects the user against microbiological, inorganic, and organic contaminants. Although reverse osmosis systems can provide a high degree of purity, healthful minerals are removed from the water and a liquid waste stream is generated which must be disposed of; the system I have designed will not remove these beneficial constituents nor will it generate a liquid waste stream.
[0003] One of the biggest drawbacks of systems which use carbon adsorption for organics (and chlorine) removal is that there is no method supplied with any system to determine the efficacy of the adsorption system. It is quite possible that subsequent to a serious distribution system event, that the homeowner would mistakenly believe that adsorption is occurring, when in fact the carbon's adsorption ability has been seriously compromised or exhausted. As such, a chlorine disinfectant residual test kit is included as part of the system (the vast majority of the time there will be a chlorine residual in the influent to the system and no residual in the effluent {which would indicate effective adsorption}).
[0004] The system is designed to produce potable water wherever there is a 12 volt power source (or other "safe" low voltage), and highly filtered water through the use of a syringe as a power source even in the event of the failure of the system's 12 volt UV portion as well as the 12 volt pump (note that as long as one of the 4 available filter cartridge slots employs a<0.45 μm filter, that pathogenic bacteria will be physically excluded).
[0005] Attached are Figures A & B, a detailed description of the "Pure-Sip" process as displayed in those Figures is as follows:
[0006] Figure "A" is a "Bird's eye" view of the system/process:
[0007] A1--influent water tank
[0008] A2--drain/supply which incorporates a quick disconnect to allow direct connection to the municipal water supply or for use as a syringe connection when B3, the system pump fails, or in emergency situations. Opening is engineered to ensure adequate contact time with NSF 55 ultraviolet disinfection system.
[0009] A3--First stage cartridge filtration at<50 μm to remove relatively large particles which can shield pathogens from ultraviolet disinfection supplied by B4. A3 is supplied by pump B3→Discharge from A3 is to ultraviolet contact chamber B5→discharge from B5 is to A4
[0010] A4-6: 2nd, 3rd, and 4th stage filtration/adsorption (and/or ionic bonding) followed by B6, a second round of NSF 55 primary UV disinfection.
[0011] A7--electrical connection/logic board/system controller
[0012] A8--removable lid to allow filling of influent tank
[0013] Figure "B" is a front elevation of the system/process:
[0014] B1--Influent tank
[0015] B2--Line from influent tank to B3 (pump)
[0016] B3--A 12 VDC (or other safe low voltage supply) powered centrifugal pump. Flow from B3 (pump) is to A3 (first stage cartridge filtration) to B5 (1st stage ultraviolet disinfection which is supplied by ultraviolet source B4)
[0017] B5--NSF 55 ultraviolet pre-disinfection→then to A4-6 (2nd, 3rd, and 4th stage filtration/adsorption).
[0018] B6--NSF 55 ultraviolet post-disinfection (subsequent to filtration/adsorption at A4-6)
[0019] B7--Supply line from ultraviolet post-disinfection to B8--effluent water tank (supplied with a quick disconnect fitting for those wishing to connect the system to a dedicated faucet at the sink). The effluent tank is bigger than the influent tank to avoid accidental spills.
[0020] B9--Electrical connection/logic board/system controller
[0021] B10--Easily removable cover to allow removal of effluent tank and/or service of components
[0022] B11--System support pads
[0023] Documentation of my efforts to gain acceptance for Point-of-Use technologies in the potable water industry's multiple barrier approach to public health includes the following national/international forums:
[0024] 1. Water Technology, November 2012
[0025] http://www.watertechonline-digital.com/201211/201211#&pageSet=0; p. 2 & p. 17-18
[0026] 2. Water Technology, August 2011 (in which essentially all aspects of my process were presented)
[0027] 3. 2011 International Conference of the Water Quality Association,
[0028] 4. 2010 National Conference of the American Water Works Association
[0029] 5. Journal of the American Water Works Association, February 2007
References Cited
TABLE-US-00001
[0030] 8,177,966 B2 May 15, 2012 Wu 7,632,410 B2 Dec. 15, 2009 Heiss 7,404,894 Jul. 29, 2008 Yamaguchi 7,252,763 B2 Aug. 7, 2007 Kuennen 2006/0186026 A1 Aug. 24, 2006 Saleh 7,090,779 Oct. 20, 2004 Berstein 6,841,876 B1 Sep. 9, 2004 Neal 6,579,445 B2 Jun. 17, 2003 Nachtman 6,478,956 Nov. 12, 2002 Kaura 6,464,884 B1 Oct. 15, 2002 Gadgil 6,451,202 B1 Sep. 17, 2002 Kuennen 6,402,949 Jun. 11, 2002 Banks 6,379,544 Apr. 30, 2002 Chen 6,344,146 Feb. 5, 2002 Moorehead 6,024,867 Feb. 15, 2000 Parise 6,120,691 Sep. 19, 2000 Mancil 5,853,572 Dec. 29, 1998 Kuennen 5,656,160 Aug. 12, 1997 Parise 5,433,848 Jul. 18, 1995 Platter 5,078,876 Jan. 7, 1992 Whittier 4,902,411 Feb. 20, 1990 Lin 4,556,484 Dec. 3, 1985 Hunter
[0031] Please note that my understanding from reading material on the USPTO website is that I am only required to document those patents granted within the past 20 years which are, or may be, related to my system (so I did not include older patents).
User Contributions:
Comment about this patent or add new information about this topic: